| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 863.72M | 964.91M | 432.30M | -227.92M | 1.05B | 374.58M |
| Gross Profit | 766.36M | 868.70M | 330.20M | -279.70M | 1.04B | 354.21M |
| EBITDA | 203.74M | 317.81M | 102.54M | -367.14M | 837.66M | 265.73M |
| Net Income | 171.87M | 258.15M | 83.61M | -326.08M | 732.99M | 211.72M |
Balance Sheet | ||||||
| Total Assets | 5.83B | 6.79B | 5.13B | 5.65B | 6.56B | 4.07B |
| Cash, Cash Equivalents and Short-Term Investments | 85.40M | 66.19M | 33.01M | 42.53M | 52.19M | 10.91M |
| Total Debt | 641.00K | 3.94M | 1.88M | 3.30M | 3.96M | 5.43M |
| Total Liabilities | 3.99B | 4.75B | 3.49B | 4.06B | 4.75B | 2.92B |
| Stockholders Equity | 1.82B | 2.02B | 1.62B | 1.58B | 1.80B | 1.10B |
Cash Flow | ||||||
| Free Cash Flow | 241.20M | 201.23M | 84.42M | 257.31M | 590.30M | 218.75M |
| Operating Cash Flow | 241.20M | 201.23M | 84.42M | 257.31M | 590.30M | 218.75M |
| Investing Cash Flow | -6.05M | -17.31M | 11.08M | -19.18M | -151.26M | -107.10M |
| Financing Cash Flow | -205.72M | -155.00M | -104.22M | -250.38M | -398.22M | -118.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | C$951.00M | 8.46 | 9.85% | 3.50% | 11.23% | 30.44% | |
77 Outperform | C$992.05M | 8.53 | 0.32% | 0.14% | -44.78% | -95.84% | |
74 Outperform | C$931.91M | 5.47 | 9.11% | ― | 22.33% | -25.06% | |
69 Neutral | C$1.65B | 10.61 | 13.82% | 2.72% | 58.88% | 82.03% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | C$671.72M | 17.89 | 11.26% | 8.82% | -0.88% | -52.30% | |
61 Neutral | C$842.14M | -12.81 | -6.98% | ― | 333.02% | -196.36% |
Senvest Capital Inc. reported a significant turnaround in financial performance for the second quarter ended June 30, 2025, with a net income of $226.3 million or $92.75 per share, compared to a net loss of $71.7 million or $29.02 per share in the same period of 2024. This substantial improvement highlights the company’s strong recovery and positive financial trajectory, which may bolster its market position and investor confidence.